Persistent gene expression changes in NAc, mPFC, and OFC associated with previous nicotine or amphetamine exposure

Behavioural Brain Research

Volumn 256, Issue , 2013, Pages 655-661

  Mychasiuk, Richelle ^a   Muhammad, Arif ^a   Ilnytskyy, Slava ^b   Kolb, Bryan ^a  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

^b UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Addiction; Epigenetic; Long Evans rat; Methylation; Psychomotor stimulant

Indexed keywords

AMPHETAMINE; DNA; MESSENGER RNA; NICOTINE; SODIUM CHLORIDE;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; DRUG ABUSE; DRUG DEPENDENCE; DRUG EXPOSURE; EPIGENETICS; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; MALE; MOLECULAR MECHANICS; NERVE POTENTIAL; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; RNA ANALYSIS; RNA SEQUENCE;

ADDICTION; EPIGENETIC; LONG-EVANS RAT; METHYLATION; PSYCHOMOTOR STIMULANT;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; EPIGENESIS, GENETIC; GENE EXPRESSION; MALE; NICOTINE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, LONG-EVANS;

EID: 84885447576     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.09.006     Document Type: Article

References (57)

1. Fagiolini M., Jensen C., Champagne F. Epigenetic influences on brain development and plasticity. Current Opinion in Neurobiology 2009, 19:207-212.
2. Borrelli E., Nestler E., Allis D., Sassone-Corsi P. Decoding the epigenetic language of neuronal plasticity. Neuron 2008, 60:961-974.
3. Robison A., Nestler E. Transcriptional and epigenetic mechanisms of addiction. Nature Reviews Neuroscience 2011, 12:623-637.
4. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004, 47(Suppl. 1):33-46.
5. Nordquist R.E., Vanderschuren L.J., Jonker A.J., Bergsma M., de Vries T.J., Pennartz C.M., et al. Expression of amphetamine sensitization is associated with recruitment of a reactive neuronal population in the nucleus accumbens core. Psychopharmacology 2008, 198:113-126.
6. Russo S., Dietz D., Dumitriu D., Morrison J., Malenka R., Nestler E. The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends in Neuroscience 2010, 33(6):267-276.
7. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genetics 2003, 33:245-254.
8. LaPlant Q., Vialou V., Covington H.E., Dumitriu D., Feng J., Warren B.L., et al. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nature Neuroscience 2010, 13(9):1137-1143.
9. Numachi Y., Yoshida S., Yamashita M., Fujiyama K., Naka M., Matsuoka H., et al. Psychostimulant alters expression of DNA methyltransferase mRNA in the rat brain. Annals of the New York Academy of Sciences 2004, 1025:102-109.
10. Maze I., Covington H.E., Dietz D.M., LaPlant Q., Renthal W., Russo S.J., et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 2010, 327:213-216.
11. Guan J.S., Haggarty S.J., Giacometti E., Dannenberg J.H., Joseph N., Gao J., et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009, 459(7243):55-60.
12. Le Merrer J., Befort K., Gardon O., Filliol D., Darcq E., Dembele D., et al. Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network. Addiction Biology 2012, 17(1):1-12.
13. Anier J., Malinovskaja K., Aonurm-Helm A., Zharkovsky A., Kalda A. DNA methylation regulates cocaine-induced behavioral sensitization in mice. Neuropsychopharmacol 2010, 35:2450-2461.
14. Freeman W.M., Brebner K., Lynch W., Robertson D., Roberts D., Vrana K. Cocaine-responsive gene expression changes in rat hippocampus. Neuroscience 2001, 108(3):371-380.
15. Saito M., Smiley J., Toth R., Vadasz C. Microarray analysis of gene expression in rat hippocampus after chronic ethanol treatment. Neurochemical Research 2002, 27(10):1221-1229.
16. Brown R.W., Kolb B. Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Research 2001, 899:94-100.
17. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychological Review 1987, 84:469-492.
18. Zilles K. The cortex of the rat: a stereotaxis atlas 1985, Springer-Verlag, Berlin.
19. Pogribny I., Yi P., James S.J. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochemical and Biophysical Research Communications 1999, 262:624-628.
20. Koturbash I., Boyko A., Rodriguez-Juarez R., McDonald R.J., Tryndyak V.P., Kovalchuk I., et al. Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo. Carcinogenesis 2007, 28:1831-1838.
21. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25(14):1754-1760.
22. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biology 2010, 11(10):R106.
23. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 1995, 57(1):289-300.
24. Kass S., Pruss D., Wolffe A. How does DNA methylation repress transcription. Trends Genet 1997, 13(11):444-449.
25. Bird A. DNA methylation patterns and epigenetic memory. Genes & Development 2002, 16:6-21.
26. Volkow N.D., Fowler J.S., Wang G.J. The addicted human brain: insights from imaging studies. Journal of Clinical Investigation 2003, 111(10):1444-1451.
27. Porrino L., Lyons D. Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models. Cerebral Cortex 2000, 10:326-333.
28. Hyman S., Malenka R., Nestler E. Neural mechanisms of addiction: the role of reward-related learning and memory. Annual Review of Neuroscience 2006, 29:565-598.
29. Kolb B. Prefrontal cortex. The cerebral cortex of the rat 1990, 437-458. MIT Press, Cambridge, MA. B. Kolb, R. Tees (Eds.).
30. Dietz D., Dietz K., Nestler E., Russo S. Molecular mechanisms of psychostimulant induced structural plasticity. Pharmacopsychiatry 2009, 42(Suppl. 1):S69-S78.
31. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., et al. Mitogen-Activated Protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 2001, 22(2):153-183.
32. 2+ and cAMP requires protein kinase A and mitogen-activated protein kinase/extracellular regulated kinase activation. The Journal of Neuroscience 2001, 21(15):5484-5493.
33. Fosnaugh J., Bhat R., Yamagata K., Worley P., Baraban J. Activation of arc: a putative effector immediate early gene, by cocaine in rat brain. Journal of Neurochemistry 1995, 64(5):2377-2380.
34. Hyman S., Malenka R. Addiction and the brain: the neurobilogy of compulsion and it's persistence. Nature Reviews Neuroscience 2001, 2(10):695-703.
35. Furushima K., Yamamoto A., Nagano T., Shibata M., Miyachi H., Abe T., et al. Mouse homologues of Shisa antagonistic of Wnt and Fgf signalings. Developmental Biology 2007, 306(2):480-492.
36. Logan C., Nusse R. The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 2004, 20:781-810.
37. Reuss B., von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell and Tissue Research 2003, 313(2):139-159.
38. Garcia M.L., Lobsiger C.S., Shah S.B., Deerinck T.J., Crum J., Young D., et al. NF-M is an essential target for the myelin-directed outside-in signaling cascade that mediates radial axon growth. The Journal of Cell Biology 2003, 163(5):1011-1020.
39. Elder G., Friedrich V., Margarita A., Lazzarini R. Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit. The Journal of Cell Biology 1999, 146(1):181-192.
40. Harashima S., Wang Y.T., Horiuchi T., Seino Y., Inagaki N. Purkinje cell protein 4 positively regulates neurite outgrowth and neurotransmitter release. Journal of Neuroscience Research 2011, 89:1519-1530.
41. Erhardt J., Legos J., Johanson R., Slemmon J., Wang X. Expression of PEP-19 inhibits apoptosis in PC12 cells. NeuroReport 2000, 11:3719-3723.
42. Slemmon J., Hughes C., Campbell G., Flood D. Increased levels of hemoglobin-derived and other peptides in Alzheimer's disease cerebellum. The Journal of Neuroscience 1994, 14:2225-2235.
43. Utal A., Stopka A., Roy M., Coleman P.D. PEP-10 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain and is dramatically reduced in Huntington's disease. Neuroscience 1989, 86:1055-1063.
44. Iwamoto K., Bundo M., Yamamoto M., Ozawa H., Saito T., Kato T. Decreased expression of NEFH and PCP4 in the prefrontal cortex of alcoholics. Neuroscience Research 2004, 49:379-385.
45. 2A receptors: a review of in vivo studies. Behavioural Brain Research 1995, 73(1-2):177-181.
46. Hondebrink L., Meulenbelt J., van Kleef R., van den Berg M., Westerink R. Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse. Neurotoxicology 2011, 32(6):823-827.
47. Barrett A., Negus S., Mello N., Caine S. Effect of GABA agonists and GABA-A receptor modulators on cocaine- and food maintained responding and cocaine discrimination in rats. The Journal of Pharmacology and Experimental Therapeutics 2005, 315(2):858-871.
48. Marinelli M., Piazza P. Interaction between glucocorticoid hormones, stress, and psychostimulant drugs. European Journal of Neuroscience 2002, 16:387-394.
49. Dobner P., Fadel J., Deitemeyer N., Carraway R., Deutch A. Neurotensin-deficient mice show altered responses to antipsychotic drugs. Proceedings of the National Academy of Sciences 2001, 98(14):8048-8053.
50. Kinkead B., Dobner P., Egnatashvili V., Murray T., Deitemeyer N., Nemeroff C. Neurotension-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol: olanzapine, or quetiapine. The Journal of Pharmacology and Experimental Therapeutics 2005, 315(1):256-264.
51. Binder E., Kinkead B., Owens M., Nemeroff C. Neurotensin and dopamine interactions. Pharmacological Reviews 2001, 53(4):453-486.
52. Kumari V., Postma P. Nicotine use in schizophrenia: the self medication hypothesis. Neuroscience and Biobehavioral Reviews 2005, 29:1021-1034.
53. Clarke T., Krause K., Li T., Schumann G. An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population. Addiction Biology 2009, 14(3):366-370.
54. Chavkin C., Shoemaker W., McGinty J., Bayon A., Bloom F. Characterization of the prodynorphin and proenkephalin neuropeptide systems in rat hippocampus. The Journal of Neuroscience 1995, 5(3):808-816.
55. Clarke T.K., Ambrose-Lanci L., Ferraro T.N., Berrettini W.H., Kampman K.M., Dackis C.A., et al. Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. Genes, Brain and Behavior 2012, 11(4):415-423.
56. Schoenbaum G., Shaham Y. The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biological Psychiatry 2008, 63(3):256-262.
57. Singer B.F., Tanabe L.M., Gorny G., Jake-Matthews C., Li Y., Kolb B., et al. Amphetamine-induced changes in dendritic morphology in rat forebrain correspond to associative drug conditioning rather than nonassociative drug sensitization. Biological Psychiatry 2009, 65(10):835-840.